![Nichol Martinuik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nichol Martinuik
Presidente en ADORBS INC. .
Perfil
Nichol Martinuik is the founder of Myspray Therapeutics, Inc. which was founded in 2012, where he holds the title of President & Director.
Currently, he is the Chairman, President & Secretary at Adorbs, Inc. where he started in 2023 and is still active.
Cargos activos de Nichol Martinuik
Empresas | Cargo | Inicio |
---|---|---|
ADORBS INC. | Presidente | 13/03/2023 |
Myspray Therapeutics, Inc.
![]() Myspray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Adorbs, Inc., Myspray Therapeutics, Inc. is a Canadian company that develops natural health products for professional results. The company is based in Canora, Canada. Myspray's products are clinically developed, licensed, and manufactured to ensure potency, quality, and safety. The company's flagship product, myshrooms, contains a potency of 40%% polysaccharides from sustainably farmed organic sources and is tested to be pure USP medicinal grade. The company was founded in 2012 by Nichol Martinuik, and Rachel Martinuik has been the CEO of the company since 2012. Myspray Therapeutics was acquired by Adorbs, Inc. on February 10, 2022 for $30.67 million. | Fundador | 01/01/2012 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ADORBS INC. | Consumer Non-Durables |
Empresas privadas | 1 |
---|---|
Myspray Therapeutics, Inc.
![]() Myspray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Adorbs, Inc., Myspray Therapeutics, Inc. is a Canadian company that develops natural health products for professional results. The company is based in Canora, Canada. Myspray's products are clinically developed, licensed, and manufactured to ensure potency, quality, and safety. The company's flagship product, myshrooms, contains a potency of 40%% polysaccharides from sustainably farmed organic sources and is tested to be pure USP medicinal grade. The company was founded in 2012 by Nichol Martinuik, and Rachel Martinuik has been the CEO of the company since 2012. Myspray Therapeutics was acquired by Adorbs, Inc. on February 10, 2022 for $30.67 million. | Commercial Services |
- Bolsa de valores
- Insiders
- Nichol Martinuik